ZTOX Insights

IIFL

IIFL

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

IIFL Finance Schedules Overseas Investor Meetings June 1–5, 2026

IIFL Finance Limited has informed exchanges about scheduling investor meetings outside India from June 1 to June 5, 2026.

Read article

AARTIPHARM

AARTIPHARM

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Aarti Pharmalabs Shares Analyst Call Transcript with NSE

Aarti Pharmalabs Limited has filed its analyst call transcript with NSE following a recent institutional investor meet. Know more about this disclosure.

Read article

GFSTEELS

GFSTEELS

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Grand Foundry (GFSTEELS): Company Update

Company Update D & A Financial Services (P) Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Equity Shareholders of Grand Foundry Ltd ("Target Company"). D & A Financial Services (P) Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Equity Shareholders of Grand Foundry Ltd ("Target Company").

Read article

IIFL

IIFL

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

IIFL Finance (IIFL): Company Update

Company Update IIFL Finance Limited informs the exchanges that the Company has scheduled meetings with institutional investors and analysts, outside India, commencing from June 01, 2026 till June 05, 2026. Enclosed herewith website link for investor presentation. IIFL Finance Limited informs the exchanges that the Company has scheduled meetings with institutional investors and analysts, outside India, commencing from June 01, 2026 till June 05, 2026. Enclosed herewith website link for investor

Read article

AARTIPHARM

AARTIPHARM

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Aarti Pharmalabs Releases Transcript from Institutional Investor Meet

Aarti Pharmalabs has notified NSE about a transcript from its recent institutional investor meet, giving market participants access to key discussion points from the interaction.

Read article

AARTIPHARM

AARTIPHARM

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Aarti Pharmalabs Posts Investor Call Transcript on NSE

Aarti Pharmalabs has disclosed its latest investor meet transcript on the NSE, giving market participants access to the company's discussion with analysts and institutional investors.

Read article

AARTIPHARM

AARTIPHARM

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Aarti Pharmalabs Submits Analyst Meeting Transcript to NSE

Aarti Pharmalabs has filed a transcript of its recent analyst and institutional investor meeting with the NSE, offering stakeholders access to the discussion details.

Read article

ZYDUSLIFE

ZYDUSLIFE

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Zydus Lifesciences Announces Buyback via NSE Filing

Zydus Lifesciences Limited has informed the NSE about initiating a share buyback program. Detailed parameters regarding pricing, size, and timeline are expected in the official filing.

Read article

AARTIPHARM

AARTIPHARM

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Q4 FY26 Earnings Call Transcript Available for Aarti Pharmalabs

The Q4 FY26 earnings call transcript for Aarti Pharmalabs is now available via BSE filing. Investors can access the full discussion covering the company's quarterly performance and strategic outlook.

Read article

ZYDUSLIFE

ZYDUSLIFE

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Zydus Lifesciences Announces Share Buyback via NSE Filing

Zydus Lifesciences Limited (NSE: ZYDUSLIFE) has notified the exchanges about a share buyback program. The announcement signals the pharma major's intent to return capital to shareholders.

Read article

ZYDUSLIFE

ZYDUSLIFE

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Zydus Lifesciences Announces Buyback: What Investors Need to Know

Zydus Lifesciences Limited has notified the exchange about a share buyback, marking another step in the pharmaceutical company's capital optimization efforts.

Read article

OMKARPH

OMKARPH

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Omkar Pharmachem Audited Q4 & FY2026 Results Published

Omkar Pharmachem (OMKARPH) has released its audited financial results for the quarter and full year ending March 31, 2026, through official newspaper publications as per regulatory guidelines.

Read article

AARTIPHARM

AARTIPHARM

Jun 4, 2026 · 1 min read

Market Updates Corporate announcement

Aarti Pharmalabs Q4 FY26 Earnings Call Transcript Now Available

Aarti Pharmalabs has released the transcript of its Q4 FY26 earnings conference call on BSE, offering investors insights into management perspectives.

Read article